Navigation Links
REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
Date:9/23/2011

ients had failed to respond to or tolerate treatment with 6-mercaptopurine, azathioprine, corticosteroids and/or 5-aminosalicylates.  Patients received REMICADE® 5 mg/kg at weeks 0, 2, and 6.  The primary endpoint, clinical response at week 8, was defined as a decrease from baseline in the Mayo score of at least 30 percent and at least 3 points, with a decrease in rectal bleeding subscore of at least 1 or a rectal bleeding subscore of 0/1.  Patients who achieved clinical response at week 8 were randomized to receive REMICADE® 5 mg/kg every 8 weeks through week 46 or every 12 weeks through week 42.  Non-responders were discontinued from study agent.  

Safety data from the pediatric UC trial were consistent with current REMICADE® labeling.  No new safety concerns emerged in evaluating REMICADE® in the treatment of a pediatric UC population.

For more information regarding the safety profile for REMICADE®, please see "Important Safety Information" below.  

About Ulcerative Colitis

Ulcerative colitis (UC) is a chronic IBD of the colon.  It is estimated that 1.4 million Americans have IBD with the number evenly split between UC and Crohn's disease.  An estimated 150,000 children under age 17 are living with debilitating symptoms of IBD.(1)  

About REMICADE®

REMICADE® was the first anti-TNF-alpha treatment approved in the United States in August 1998 and the first TNF inhibitor to be approved in three different therapeutic areas: gastroenterology, rheumatology and dermatology.  REMICADE® has demonstrated broad clinical utility with indications in Crohn's disease, rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, ulcerative colitis (UC), pediatric Crohn's disease, psoriasis, and pediatric UC.  The safety and efficacy of REMICADE® have been well established in clinical trials over
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement
2. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
3. FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Oct. 20, 2014  AnaptysBio, Inc., a leader ... today announced the appointment of Marco Londei ... will lead the preclinical and clinical development of ... are pleased to welcome Dr. Londei to AnaptysBio,s ... President and Chief Executive Officer of AnaptysBio. "Dr. ...
(Date:10/20/2014)... -- Pharmaceutic Labs announces the opening of its specialty ... for admixing, compounding, drug shortages and clinical ... FDA standards for safety and quality, using 21 CFR ... The 10,000 square foot outsourcing facility was designed ... quality control. The company will produce sterile and non-sterile ...
(Date:10/20/2014)... N.C., Oct. 20, 2014  BioPontis Alliance for ... both philanthropies, announced today the creation of a ... treatment of the rare disease known as Charcot- ... its alliance model earlier this month. Today,s partnership ... a collaborative model where researchers and all CMT ...
Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3
... 2011 Echo Therapeutics, Inc. (OTCBB: ... as a non-invasive, wireless, transdermal continuous glucose monitoring ... transdermal drug delivery, announced that it has received ... tCGM System design.  This newly-engineered design is currently ...
... Reportlinker.com announces that a new market research ... Advanced Digital Medical Equipment Products ... http://www.reportlinker.com/p0507254/Advanced-Digital-Medical-Equipment-Products-Market .html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging This report ... device markets, particularly focusing on the US ...
Cached Medicine Technology:Echo Therapeutics Announces Symphony™ tCGM System Progress 2Echo Therapeutics Announces Symphony™ tCGM System Progress 3Reportlinker Adds Advanced Digital Medical Equipment Products Market 2Reportlinker Adds Advanced Digital Medical Equipment Products Market 3Reportlinker Adds Advanced Digital Medical Equipment Products Market 4Reportlinker Adds Advanced Digital Medical Equipment Products Market 5Reportlinker Adds Advanced Digital Medical Equipment Products Market 6Reportlinker Adds Advanced Digital Medical Equipment Products Market 7Reportlinker Adds Advanced Digital Medical Equipment Products Market 8Reportlinker Adds Advanced Digital Medical Equipment Products Market 9Reportlinker Adds Advanced Digital Medical Equipment Products Market 10Reportlinker Adds Advanced Digital Medical Equipment Products Market 11Reportlinker Adds Advanced Digital Medical Equipment Products Market 12
(Date:10/20/2014)... Pittsburgh, PA (PRWEB) October 20, 2014 ... new, minimally-invasive procedure that enables physicians to repair a ... , The MitraClip system, developed by ... regurgitation (MR), a progressive and life-threatening condition in which ... allowing blood to flow backward from the heart’s left ...
(Date:10/20/2014)... OH (PRWEB) October 20, 2014 Women’s ... Specialists in Obstetrics & Gynecology of Columbus, Inc., A ... women’s healthcare services to more than 100,000 patients annually. ... though all ages and stages of a women’s life. ... office locations in Westerville and Dublin. , Dr. ...
(Date:10/20/2014)... 20, 2014 Zereana Jess-Huff, a 34-year-old mother, ... 2014 on a platform to think outside the bra. She ... her position to raise awareness about women’s other lady parts. ... cancer. You say the color pink and everybody knows what ... a fact that it has not been won when it ...
(Date:10/20/2014)... 20, 2014 Principle Business Enterprises, a ... in manufacturing top-of-the-line absorbent products. The company has ... most popular brand, Tranquility® Premium Protection absorbent products. ... website, gave its packaging a new look, and is ... message to the public. , The new website, developed ...
(Date:10/20/2014)... Rockynol Retirement Community broke ground on ... $11 million project will include the latest in Assisted ... full-service restaurant style dining. , “We are excited to ... Living apartments,” said Kara Hanzie, Rockynol Executive Director during ... care and this investment is proof of our commitment.” ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2
... a national leader in accounts receivable management, and collection services to ... created position of Chief Operating Officer (COO). , ... ... leader, MDS ( www.meddatsys.com ), has announced Eugene (Gene) Schneider to ...
... cause irreversible damage, doctors say , , WEDNESDAY, March 18 (HealthDay ... death Wednesday of actress Natasha Richardson, reports that she suffered ... Canadian ski slope on Tuesday have many people wondering how ... of the most lauded acting families in Great Britain; her ...
... "The White House made the correct decision ... Veterans Affairs to have military veterans, personal insurance ... said VAdm. Norb Ryan, Jr., USN-Ret., president of ... said he advised President Obama that "pursuing this ...
... cents donated for every person that playsPHOENIX, March 18 ... home products, is kicking off The Candle Game to benefit ... the free online game, Gold Canyon will donate 10 cents ... Game can be played online at http://thecandlegame.com and ...
... was 98% for Kit-positive GIST patients taking Gleevec vs. ... patients experienced recurrence of GIST(2) within a median of ... treatment in the US and Switzerland indicated to reduce ... is underway in the EU(4) EAST HANOVER, N.J., March ...
... March 18 Speaker Nancy Pelosi announced this afternoon ... that could have forced veterans to use their private insurance ... Pelosi made the announcement at a meeting she and House ... veterans, service organizations, who greeted the news with a standing ...
Cached Medicine News:Health News:Medical Data Systems, Inc. (MDS) Announces New Chief Operating Officer (COO) 2Health News:Medical Data Systems, Inc. (MDS) Announces New Chief Operating Officer (COO) 3Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 2Health News:Brain Hemorrhage Might Explain Natasha Richardson's Death 3Health News:White House Makes Correct Decision On Veterans Insurance Proposal 2Health News:Gold Canyon Ignites Hope With Online Charity Candle Game 2Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 2Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 3Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 4Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 5Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 6Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 7Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 8Health News:Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports 9Health News:Pelosi: Administration Will Not Force Veterans to Use Private Insurance to Pay for Treatment of Combat-Related Injuries 2
Allows for custom orientation of specimen...
Honing compound for knife sharpening, 6 grams net...
Standard knife with box, C profile...
... sectioning work, it is necessary to cool a ... can be fitted to most microtomes and will ... lower, depending on conditions. The equipment consists of ... cooling stage is best suited for operation with ...
Medicine Products: